Timing of birth and disease progression in multiple sclerosis

Abstract

Background

The timing of birth has recently been associated with the risk of developing multiple sclerosis (MS) in later life. Whether the timing of birth also influences the disease course of MS is unknown.

Objective

To investigate whether the season or month of birth influences the timing of secondary progression or the time to landmark disability outcomes in MS.

Methods

To allow confirmation of findings, all analyses were performed in duplicate in two large natural history cohorts from geographically distinct but seasonally similar locations in Europe and North America. Kaplan–Meier survival analyses were used to investigate the influence of month and season of birth on 1) the time to and age at the development of secondary progression in patients with a relapsing disease onset and 2) the time to reach an Expanded Disability Status Scale (EDSS) score of 6.0 in patients with primary progressive and relapsing MS.

Results

No association between the month or season of birth and disease progression could be found, which was reproducible in both natural history cohorts. A seasonal trend was observed for the time to and age at secondary progression in Groningen, with March babies exhibiting a shorter time to and younger age at secondary progression. The birth month affected time to EDSS 6 for those with relapsing MS in British Columbia, with January babies exhibiting a longer time to EDSS 6. Neither finding could be reciprocated in the other natural history cohort.

Conclusion

The season or month of birth does not appear to influence disease progression of MS.

Keywords

disability multiple sclerosis progressive risk factor

Get full access to this article

View all access options for this article.

References

1 Willer C Dyment D Sadovnick A Rothwell P Murray T Ebers G . Timing of birth and risk of multiple sclerosis: population based study . BMJ 2005; 330: 120 – 124 .

2 Tremlett H Devonshire V . Does the season or month of birth influence disease progression in multiple sclerosis . Neuroepidemiology 2006; 26: 195 – 198 .

3 Sadovnick A Duquette P Herrera B Yee I Ebers G . A timing-of-birth effect on multiple sclerosis clinical phenotype . Neurology 2007; 69: 60 – 62 .

4 Sweeney V Sadovnick A Brandejs V . Prevalence of multiple sclerosis in British Columbia . Can J Neurol Sci 1986; 13: 47 – 51 .

5 Sadovnick A Ebers G Wilson R Paty D . Life expectancy in patients attending multiple sclerosis clinics . Neurology 1992; 42: 991 – 994 .

6 Tremlett H Paty D Devonshire V . The natural history of primary progressive MS in British Columbia, Canada . Neurology 2005; 65: 1919 – 1923 .

7 Tremlett H Devonshire V . Is late-onset multiple sclerosis associated with a worse outcome . Neurology 2006; 67: 954 – 959 .

8 Tremlett H Paty D Devonshire V . Disability progression in multiple sclerosis is slower than previously reported . Neurology 2006; 66: 172 – 177 .

9 Tremlett H Zhao Y Devonshire V . The natural history of secondary-progressive multiple sclerosis . Mult Scler 2008; 14: 314 – 324 .

10.

10 Minderhoud J van der Hoeven J Prange A . Course and prognosis of chronic progressive multiple sclerosis. Results of an epidemiological study . Acta Neurol Scand 1988; 78: 10 – 15 .

11.

11 Koch M Mostert J Heersema D De Keyser J . Progression in multiple sclerosis: further evidence of an age dependent process . J Neurol Sci 2007; 255: 35 – 41 .

12.

12 Poser C Paty D Scheinberg L . New diagnostic criteria for multiple sclerosis: guidelines for research protocols . Ann Neurol 1983; 13: 227 – 231 .

13.

13 Lublin F Reingold S . Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) advisory committee on clinical trials of new agents in Multiple Sclerosis . Neurology 1996; 46: 907 – 911 .

14.

14 Kremenchutzky M Rice G Baskerville J Wingerchuk D Ebers G . The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease . Brain 2006; 129: 584 – 594 .

15.

15 Holick MF . Vitamin D deficiency . N Engl J Med 2007; 357: 266 – 281 .